About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Biology of Blood and Marrow Transplantation
›
Top Articles
Biology of Blood and Marrow Transplantation
Transplantation
,
Hematology
4.7
(top 8%)
Impact Factor
5.1
(top 8%)
extended IF
133
(top 2%)
H-Index
2.9K
authors
5.9K
papers
166.4K
citations
4.4K
citing journals
35.3K
citing authors
Most Cited Articles of Biology of Blood and Marrow Transplantation
Title
Year
Citations
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
2005
2.7K
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
2009
1.2K
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report
2015
1.2K
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
2008
1.2K
Defining the intensity of conditioning regimens: working definitions
2009
1.1K
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
2019
874
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients
2005
675
Chronic graft-versus-host disease
2003
654
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
2015
415
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome
2010
406
First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation
2012
399
Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans
2010
383
Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation
2005
375
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report
2006
357
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies
2003
348
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report
2006
344
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease
2009
339
Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease
2014
336
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide
2002
335
Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation
2005
331
Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers
2001
328
Transplantation of ex vivo expanded cord blood
2002
326
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems
2002
310
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation
2006
287
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report
2006
287
previous
2008
2009
2010
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.